Midland Research Group, Inc.
2 clinical trials · Sponsor
◉ Watch Midland Research Group, Inc.
| Record | Firm | Date |
|---|---|---|
| Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) (NCT04240210) | Midland Research Group, Inc. | 2019-09-17 |
| Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1 (NCT03502005) | Midland Research Group, Inc. | 2018-03-01 |
Track Midland Research Group, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.